enow.com Web Search

  1. Ads

    related to: parkinson's disease treatment drugs
    • Recent HD Diagnosis?

      Learn About HD Chorea Symptoms &

      Educate Yourself For Your Journey.

    • Access FAQs

      See Answers To FAQs About Patients

      With Huntington's Disease & Chorea.

Search results

  1. Results from the WOW.Com Content Network
  2. Management of Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Management_of_Parkinson's...

    Pharmacological treatment of Parkinson's disease. The main families of drugs useful for treating motor symptoms are levodopa, dopamine agonists, and MAO-B inhibitors. [3] The most commonly used treatment approach varies depending on the disease stage.

  3. Hope for Parkinson’s disease symptoms is found in ... - AOL

    www.aol.com/finance/hope-parkinson-disease...

    Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great promise in a Phase III trial by AbbVie, the pharmaceutical company announced this week.. Parkinson’s disease ...

  4. Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Parkinson's_disease

    Parkinson's typically manifests in individuals over 60, with about one percent affected. In those younger than 50, it is termed "early-onset PD". No cure for Parkinson's is known, and treatment focuses on alleviating symptoms. Initial treatment typically includes L-DOPA, MAO-B inhibitors, or dopamine agonists.

  5. Dopamine agonist - Wikipedia

    en.wikipedia.org/wiki/Dopamine_agonist

    Dopamine agonists are mainly used in the treatment of Parkinson's disease. [2] The cause of Parkinson's is not fully known but genetic factors, for example specific genetic mutations, and environmental triggers have been linked to the disease. [4] In Parkinson's disease dopaminergic neurons that produce the neurotransmitter dopamine in the ...

  6. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

    www.aol.com/finance/fda-approves-abbvies...

    On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...

  7. A Potential Parkinson's Treatment Has Promising Results - AOL

    www.aol.com/potential-parkinsons-treatment...

    The trial—conducted by researchers at the University of Texas, the Mayo Clinic, the Michael J. Fox Foundation for Parkinson’s Research, and Vaxxinity—included 20 people with Parkinson’s.

  1. Ads

    related to: parkinson's disease treatment drugs